Black Diamond’s Cancer Drug May Be a ‘Master Key\,’ Street Says
Black Diamond’s Cancer Drug May Be a ‘Master Key,’ Street Says
Bookmark
(Bloomberg) -- After doubling from a January debut, Black Diamond Therapeutics Inc. is drawing rave reviews from all four banks that are now giving the stock research coverage.